Dexamethasone May Hinder Immunotherapy for Glioblastoma
THURSDAY, Dec. 3, 2020 — For patients with glioblastoma (GBM) receiving immune checkpoint inhibitors, concurrent dexamethasone is associated with worse
Read more
New immunotherapy shows promise against rare childhood cancer
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumors, has shown promising early
Read more
Study identifies patients with lung cancer most likely to respond to immunotherapy
Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people with cancer respond to the
Read more
Immunotherapy may work better in stomach cancer when combined with chemo, given earlier
Immunotherapy for stomach cancer may work better if the therapy is delivered earlier in the course of disease and in
Read more
Taking the itch out of cancer immunotherapy
Using the body’s immune system to fight cancer has great potential, but can also bring serious side effects, including itchy
Read more
Immunotherapy combo halts rare, stage 4 sarcoma in teen
A patient with end-stage and rapidly progressing soft-tissue cancer whose tumor did not respond to standard treatment, had a “rapid
Read moreImmunotherapy Combo Treats Advanced Kidney Cancer
FRIDAY, Oct. 2, 2020 — Nivolumab combined with cabozantinib is superior to sunitinib alone for the treatment of advanced clear
Read more
Researchers ID new target in drive to improve immunotherapy for cancer
Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy
Read more
Research uncovers clues in use of immunotherapy for breast cancer
UC researchers have found a potential new combination therapy for breast cancer that would integrate use of the body’s immune
Read more
NIH investigators hope CD47 study leads to infectious diseases immunotherapy
NIH investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or
Read more